DEXCOM INC (DXCM) Risk Factors
Health CareLatest 10-Q filed Jul 30, 2026Source: SEC EDGAR
WealthWire extracted and classified 1 risk factors from DEXCOM INC’s latest SEC filing, mapping each to a standardized risk taxonomy so they can be compared across every company and sector. The breakdown below shows how those disclosures distribute across risk categories.
Financial
1 factorsRecent key developments
Concrete developments — dated events, named agreements and instruments, legal proceedings — that DEXCOM INC surfaced in its latest filing.
- Board authorized the 2026 Share Repurchase Program for up to $1.00 billion of outstanding common stock.
- Under the 2026 Share Repurchase Program, the repurchase period ends no later than June 30, 2027.June 30, 2027
- Board terminated the existing share repurchase program, which had $250.0 million remaining.
- 8.6 million shares repurchased under the 2026 Share Repurchase Program during the three and six months ended June 30, 2026.June 30, 2026
Go deeper on DXCM
This page shows the category breakdown of the latest filing. The WealthWire API and dashboard add the full risk-factor text, multi-year trends, sector comparisons, and CSV export — for DXCM and every other S&P 500 company.